newsfilter
← Latest News
GlobeNewswire·

Iambic to participate in Jefferies Global Healthcare Conference

  • Iambic (NASDAQ: IAM) announced that Co-Founder & CEO Tom Miller, PhD will attend the Jefferies Global Healthcare Conference in London from November 16-19, 2026.
  • Dr. Miller will participate in a panel on AI in drug discovery on November 18 at 2:00 PM GMT.
  • The 17th annual Jefferies Global Healthcare Conference is Europe's largest healthcare-focused event featuring leaders in pharma, biotech, & health IT.
  • Dr. Miller stated Iambic aims to improve medicine development success rates by integrating insights across chemistry, biology, & clinical development using its molecular superintelligence platform.
  • Iambic's platform led to the discovery of IAM1363, a novel drug candidate advanced to the clinic in approximately two years, alongside a diverse preclinical pipeline.
  • The company utilizes AI technologies Enchant & NeuralPLexer for multimodal endpoint prediction to enhance drug discovery speed, precision, & success rates.
  • The press release includes standard forward-looking statements regarding the conference, platform potential, & pipeline strategy, citing risks that could cause actual results to differ from projections.